Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Viridian Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
138
+4 vs. Q1 2024
Shares held
69.6M
−1.13M (−1.6%) vs. Q1 2024
Total value
$906.2M
−$333.2M (−26.9%) vs. Q1 2024
New holders
20
70 more added
Sold out
16
28 more reduced

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 138 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ2 2024: $906.2M
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding VRDN in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Russell Investments Group, Ltd.349,631$4.55M0.01%+28,025+8.7%Added
Eagle Asset Management Inc373,462$4.93M0.03%−65,305−14.9%Reduced
Fisher Asset Management, LLC395,497$5.15M0.00%+6,410+1.6%Added
Woodline Partners LP400,915$5.22M0.05%−38,007−8.7%Reduced
Two Sigma Investments, LP419,820$5.46M0.01%+192,966+85.1%Added
Walleye Capital LLC430,596$5.60M0.06%+424,960+7,540.1%Added
Northern Trust Corp479,881$6.24M0.00%+17,201+3.7%Added
Charles Schwab Investment Management Inc483,921$6.30M0.00%+59,836+14.1%Added
Nuveen Asset Management, LLC498,403$6.48M0.00%−834,051−62.6%Reduced
Great Point Partners LLC500,000$6.50M1.25%−835,000−62.5%Reduced
Two Sigma Advisers, LP526,700$6.85M0.02%+222,300+73.0%Added
Eversept Partners, LP567,487$7.38M0.57%+425,412+299.4%Added
Ghost Tree Capital, LLC587,708$7.65M2.66%−37,292−6.0%Reduced
RTW Investments, LP605,816$7.88M0.12%00.0%Unchanged
Octagon Capital Advisors LP620,000$8.07M1.33%00.0%Unchanged
5AM Venture Management, LLC736,595$9.58M2.14%00.0%Unchanged
Candriam Luxembourg S.C.A.749,804$9.75M0.06%+469,804+167.8%Added
Polar Capital Holdings Plc889,198$11.6M0.07%00.0%Unchanged
Yiheng Capital Management, L.P.948,130$12.3M1.74%00.0%Unchanged
Goldman Sachs Group Inc999,941$13.0M0.00%+456,801+84.1%Added
Pictet Asset Management Holding SA1,022,104$13.3M0.02%−73,337−6.7%Reduced
Tang Capital Management LLC1,392,925$18.1M1.85%+700,000+101.0%Added
Geode Capital Management, LLC1,411,360$18.4M0.00%+247,088+21.2%Added
Perceptive Advisors LLC1,631,828$21.2M0.51%−2,025,271−55.4%Reduced
Vivo Capital, LLC1,678,207$21.8M2.02%00.0%Unchanged
Kynam Capital Management, LP1,750,000$22.8M2.38%+1,616,123+1,207.2%Added
Fairmount Funds Management LLC1,845,813$24.0M2.71%00.0%Unchanged
Alliancebernstein L.P.1,998,192$26.0M0.01%+275,373+16.0%Added
Novo Holdings A/S2,000,000$26.0M1.40%+900,000+81.8%Added
Commodore Capital LP2,528,032$32.9M2.25%+593,379+30.7%Added
State Street Corp2,772,379$36.1M0.00%−1,716,236−38.2%Reduced
Paradigm Biocapital Advisors LP2,896,349$37.7M1.44%−2,135,071−42.4%Reduced
Maverick Capital LtdSuperinvestorMaverick Capital3,307,945$43.0M0.82%+615,531+22.9%Added
Vanguard Group Inc3,345,731$43.5M0.00%+111,452+3.4%Added
VR Adviser, LLC3,882,671$50.5M3.22%00.0%Unchanged
Deep Track Capital, LP3,923,849$51.0M1.52%+467,796+13.5%Added
BlackRock Inc.4,773,622$62.1M0.00%+960,992+25.2%Added
FMR LLC9,573,348$124.5M0.01%+158,213+1.7%Added
Logos Global Management LP0$00.00%−700,000−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−614,010−100.0%Sold out
Cutter Capital Management, LP0$00.00%−278,638−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−69,430−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−28,822−100.0%Sold out
Lighthouse Investment Partners, LLC0$00.00%−28,406−100.0%Sold out
American International Group, Inc.0$00.00%−24,515−100.0%Sold out
E Fund Management Co., Ltd.0$00.00%−19,323−100.0%Sold out
Bellevue Group AG0$00.00%−19,100−100.0%Sold out
Metropolitan Life Insurance Co0$00.00%−2,632−100.0%Sold out
Orion Capital Management LLC0$00.00%−200−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−187−100.0%Sold out
Harbour Investments, Inc.0$00.00%−66−100.0%Sold out
Fortitude Family Office, LLC0$00.00%−29−100.0%Sold out
Game Plan Financial Advisors, LLC0$00.00%−13−100.0%Sold out
Nelson, Van Denburg & Campbell Wealth Management Group, LLC0$00.00%−8−100.0%Sold out
Kopp LeRoy C––––Not filed
Credit Suisse AG––––Not filed